KPTI's Chief Medical Officer Jatin Shah just bought over 23,000 shares at around 8.60 for sum of $200,000. What an endorsement from someone in the know. Bash on Prasad and Goodman.
Funny how these chaps don't disclose their potential conflict of interest here. Bashing a life saving great drug that happens to have a huge short positions with hedge funds wanting to make millions by distorting the facts -- classic short and distort may be at play here. Just look in their background and see for yourselves their past associations.
That's an interesting claim. I wonder if you can be more specific about Goodman and Prasad's short positions with Karyopharm stock. Do you have a source for the claim? Would be good to know if true.
@@joelpollen I didn't say they have a short position. I said potential conflict of interest (based on their "consulting" work)... I will be more specific in an article. Feel free to join my mailing list www.rezamusic.com
@@RezaGanjavi It seems like you are suggesting that someone has a short position, since you mentioned shorting twice in your original comment. Are you saying Prasad and Goodman are being paid consulting fees by hedge funds that have short positions? I'm unable to find anything about them working for hedge funds, so it would be great if you could share your source. It's difficult to take your claim seriously without evidence.
@@joelpollen It's difficult to take you seriously since your first question showed you didn't read my statement correctly, and your second question is not much better. I don't care if you want to take me seriously or not. I said exactly what I meant to say using exactly the words I wanted to use. Beyond that, if you want more specifics I told you what you can do. I might post it here or not once I'm done writing it up. Till then you can assume what you want but your thoughts are not my words. So stop trying to put words in my mouth. Thank you.
Dr Prasad's rant at the end was awesome. 🔥🔥🔥
Totally true. Loved it.
KPTI's Chief Medical Officer Jatin Shah just bought over 23,000 shares at around 8.60 for sum of $200,000. What an endorsement from someone in the know. Bash on Prasad and Goodman.
I really appreciate your help Dr Onosetale
cool plenary session! thank you
Funny how these chaps don't disclose their potential conflict of interest here. Bashing a life saving great drug that happens to have a huge short positions with hedge funds wanting to make millions by distorting the facts -- classic short and distort may be at play here.
Just look in their background and see for yourselves their past associations.
That's an interesting claim. I wonder if you can be more specific about Goodman and Prasad's short positions with Karyopharm stock. Do you have a source for the claim? Would be good to know if true.
@@joelpollen I didn't say they have a short position. I said potential conflict of interest (based on their "consulting" work)... I will be more specific in an article. Feel free to join my mailing list www.rezamusic.com
@@RezaGanjavi It seems like you are suggesting that someone has a short position, since you mentioned shorting twice in your original comment. Are you saying Prasad and Goodman are being paid consulting fees by hedge funds that have short positions? I'm unable to find anything about them working for hedge funds, so it would be great if you could share your source. It's difficult to take your claim seriously without evidence.
@@joelpollen It's difficult to take you seriously since your first question showed you didn't read my statement correctly, and your second question is not much better. I don't care if you want to take me seriously or not. I said exactly what I meant to say using exactly the words I wanted to use. Beyond that, if you want more specifics I told you what you can do. I might post it here or not once I'm done writing it up. Till then you can assume what you want but your thoughts are not my words. So stop trying to put words in my mouth. Thank you.